Examples of 'moderate hepatic' in a sentence
Meaning of "moderate hepatic"
Moderate hepatic is a medical term used to describe the severity or level of impairment of the liver, specifically referring to a moderate degree of liver involvement or damage. It is typically used to assess the extent of liver disease or dysfunction and may influence treatment decisions or interventions for managing the condition
How to use "moderate hepatic" in a sentence
Basic
Advanced
moderate hepatic
Moderate hepatic damage caused extensive darifenacin retention.
No dose adjustment is required in mild to moderate hepatic impairment.
Use in patients with moderate hepatic impairment or biliary obstruction.
Caution should be exercised if patients have moderate hepatic disease.
Mild to moderate hepatic impairment.
Or regarding pharmacokinetics in moderate hepatic impairment.
Mild to moderate hepatic impairment had little effect on quinidine pharmacokinetics.
Mg once daily in subjects with moderate hepatic impairment.
Moderate hepatic impairment did not affect the pharmacokinetics of eslicarbazepine acetate.
Limited information is available in patients with moderate hepatic impairment.
Patients with mild or moderate hepatic impairment should be monitored closely.
Closely monitor patients with mild and moderate hepatic impairment.
In patients with moderate hepatic impairment the exposure of ospemifene and.
Qtern can be used in patients with mild or moderate hepatic impairment.
Mild and moderate hepatic impairment had no impact on the pharmacokinetic of teriflunomide.
See also
Rasagiline use in patients with moderate hepatic impairment should be avoided.
Data are insufficient to draw conclusions regarding pharmacokinetics in moderate hepatic impairment.
Patients with moderate hepatic impairment showed an increased frequency of adverse reactions.
No dose adjustment is needed in patients with mild to moderate hepatic impairment.
Patients with mild and moderate hepatic impairment were included in clinical trials.
Data are insufficient to draw conclusions in patients with moderate hepatic impairment.
Patients with moderate hepatic impairment should be evaluated prior to initiation and during treatment.
There is no need for dose adjustment in mild to moderate hepatic impairment.
In patients with mild to moderate hepatic impairment Onduarp should be administered with caution.
No dose adjustment is required in patients with mild to moderate hepatic impairment.
In patients with mild to moderate hepatic impairment the posology should not exceed Tolucombi.
No dose adjustment is required in patients with mild or moderate hepatic impairment.
In subjects with moderate hepatic impairment i . e.
Closer monitoring is advised in patients with mild or moderate hepatic impairment.
For adults with moderate hepatic impairment Child-Pugh score.
Xultophy can be used in patients with mild or moderate hepatic impairment.
For patients with mild or moderate hepatic impairment, no dose adjustment is required.
There were no relevant changes in pharmacokinetics of oritavancin in subjects with moderate hepatic impairment.
The use of nelfinavir in patients with moderate hepatic impairment has not been studied.
Degarelix has been investigated in a pharmacokinetic study in patients with mild to moderate hepatic impairment.
Experience is limited in patients with moderate hepatic disease who may have bleeding diatheses.
No dose adjustment of cobicistat is required in patients with mild or moderate hepatic impairment.
For patients with mild or moderate hepatic impairment, dosing can be initiated at 2 mg.
Dose adjustment is not necessary in patients with mild or moderate hepatic impairment.
Effects of mild and moderate hepatic impairment were evaluated in a single dose phase 1 study.
No dose adjustment is considered necessary unless moderate hepatic impairment exists.
In patients with mild to moderate hepatic impairment telmisartan / amlodipine should be administered with caution.
Odefsey should be used with caution in patients with moderate hepatic impairment.
One patient who had moderate hepatic steatosis also presented elevated blood glucose, but no cholelithiasis.
No dose adjustment is necessary for patients with mild to moderate hepatic impairment.
Individuals with moderate hepatic impairment should start at 5 mg of Levitra.
No dose adjustment is needed for patients with mild to moderate hepatic impairment.
In HCV negative patients with moderate hepatic impairment, reduced exposure to telaprevir was observed.
No dose adjustment is deemed necessary in patients with mild or moderate hepatic impairment.
Mg for moderate hepatic impairment from one 50 mg vial.
You'll also be interested in:
Examples of using Hepatic
Show more
Progressive renal or hepatic end organ dysfunction
Hepatic toxicity has been associated with acetaminophen
Monitoring of the hepatic function is also recommended
Examples of using Moderate
Show more
There are moderate to large amounts of ketones in urine
Most undesirable effects were mild to moderate in severity
Exert only moderate pressure on the workpi
